Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2025-12-25 @ 12:38 AM
NCT ID:
NCT02604667
Eligibility Criteria:
Inclusion Criteria
* 18 years of age or older
* Active solid tumor cancer (for Groups 1 and 3 only)
* MRI confirmed acute ischemic stroke (for Groups 1 and 2 only)
* Available for blood draw at 96 hours (+/- 24 hours) from last known well time (for Groups 1 and 2 only) or within 2 weeks of enrollment (for Group 3)
* Available for TCD within 2 weeks of enrollment
Exclusion Criteria
* Primary brain tumor or hematological cancer
* Treatment with intravenous or intraarterial thrombolysis or mechanical embolectomy
* Platelets \< 50,000/mm3
* Hemodialysis within 14 days
* Active pregnancy
* Infection within 14 days per Infectious Diseases Society of America (IDSA) criteria
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02604667
Study Brief:
Protocol Section:
NCT02604667